Wyss InstituteSearch Results for “organ-on-a-chip” – Wyss Institute

Cutting to the Case: Don Ingber

Jessica Leff — Fri, 11 Sep 2026 13:56:59 +0000

Don Ingber, M.D., Ph.D., is the Founding Director of Harvard University’s Wyss Institute for Biologically Inspired Engineering and a pioneer of organ-on-a-chip technology. In this episode of Cutting to the Case, Ingber and host Cameron Sabet discuss how he helped create organs-on-chips, what these systems can teach us that traditional models cannot, and how biologically inspired engineering…

Source

Postdoctoral Fellow – NHP Immunology and Organ Chips

Jessica Leff — Thu, 20 Aug 2026 13:50:30 +0000

The Wyss Institute for Biologically Inspired Engineering at Harvard University seeks outstanding postdoctoral applicants with expertise in non-human primate immunology and virology or analysis of spatial omics data to join an interdisciplinary team of biologists and engineers to leverage in vitro organ-on-a-chip (Organ Chip) microfluidic culture systems to study and model and compare adaptive…

Source

Postdoctoral Fellow – Computational Immunology & Translational Oncology

Jessica Leff — Tue, 30 Jun 2026 20:40:42 +0000

The Wyss Institute for Biologically Inspired Engineering at Harvard University seeks outstanding postdoctoral applicants with expertise in immunology and computational biology, specifically bulk/single cell sequencing and AI/ML workflows, to join an interdisciplinary team of biologists and engineers to leverage in vitro organ-on-a-chip (Organ Chip) microfluidic culture systems and injectable…

Source

Human organ-on-a-chip technology as a catalyst for drug discovery

Jessica Leff — Thu, 25 Jun 2026 13:33:05 +0000

Decoding inflammatory bowel disease – on a chip

Jessica Leff — Thu, 21 May 2026 09:30:43 +0000

By Benjamin Boettner (BOSTON) — Inflammatory bowel disease (IBD), which comprises the inflammatory conditions Crohn’s disease and ulcerative colitis, affects about 1.6 million Americans, many of whom cannot be effectively treated. This is mostly due to a lack of understanding of what exactly causes the increased inflammation, fibrosis, and compromised intestinal barrier that underlie this…

Source

Beyond Animals: Revolutionizing Drug Discovery with Human-Relevant Models

Jessica Leff — Wed, 02 Apr 2025 12:55:09 +0000

Code to Cure is a newsletter co-hosted by the Wyss Institute at Harvard University and Milad Alucozai on the intersection of AI, biology, and healthcare transforming medicine. By Milad Alucozai, Abishek Kulshreshtha, Megan Sperry, and Klaus Romero The average new drug requires over 15 years and $2 billion in funding to traverse the journey from discovery to full approval.

Source

TapeTech microfluidic connectors: adhesive tape-enabled solution for organ-on-a-chip system integration

Jessica Leff — Thu, 06 Feb 2025 17:20:07 +0000

Ela Contreras-Panta, Ph.D.

Jessica Leff — Mon, 03 Feb 2025 13:29:23 +0000

Ela received her B.Sc. in Genetics and Biotechnology at Universidad Nacional Mayor de San Marcos, Peru. After that, she worked at the Peruvian National Cancer Institute as a research assistant working to adapt new sequencing techniques to detect point mutations in leukemia patients. In 2018, Ela became a student intern at Vanderbilt University studying early brain development using iPSCs and…

Source

ARPA-H-recognized iNode team seeks vital support to treat ovarian cancer with first-in-class implantable immune organs

Mariel Schoen — Thu, 30 Jan 2025 20:13:20 +0000

(BOSTON) — Ovarian cancer is deadlier than any other type of female reproductive organ cancer. It is estimated that in 2024, in the U.S. alone, more than 12,000 women will die from the disease because available therapies are not effective. To help overcome this striking deficit in women’s health, a team at the Wyss Institute at Harvard University has developed “iNodes…

Source

Wyss Institute’s iNodes team receives ARPA-H Sprint for Women’s Health award to advance the first implantable immune organs to treat ovarian cancer

Jessica Leff — Tue, 12 Nov 2024 14:58:41 +0000

By Benjamin Boettner (BOSTON) — Ovarian cancer is more deadly than any other type of female reproductive organ cancer. It is estimated that in 2024, in the U.S. alone, more than 12,000 women will die from the disease because available therapies are not effective. To help overcome this striking deficit in women’s health, ARPA-H has selected a team at the Wyss Institute at Harvard University as…

Source